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Immunosuppressive agents, those which suppress or prevent various
phases of the immune response, have been used experimentally to analyze
the basic cellular and molecular events involved in normal immune
responses and have been applied clinically during therapeutic pro
grams for organ transplantation, autoimmune disease, and malignancy.
The immune mechanism encompasses several overlapping stages, primarily
the afferent arm or induction of immunity and the efferent arm or expres
sion of immunity. In addition, the immune response consists of two
distinct cell compartments. Thymus-derived lynqphocytes, T cells,
differentiate into cells functioning in cellular immunity while bonemarrow-derived lynqphocytes, B cells, are activated to produce and
secrete antibody. With regard to the type of drug, dosage, schedule,
and route of administration, any of the levels of the Immune response
are subject to suppression.
In this study four drugs were investigated superficially in an attempt
to understand the interaction of drugs and the immune response and
to define the lymphoid cell population(s) most susceptible to suppression.
Emphasis was placed on hydrocortisone acetate while azathioprine,
niridazole, and methotrexate were studied in less detail. Immuno
suppressive effects on induction and expression of cellular immunity
were accomplished by assaying the delayed hypersensitivity (DH) response
of drug-treated animals to the chemical sensitizing agent oxazolone.
Suppression of humoral immune induction was measured by antibody pro
duction of rabbit red blood cells and by spleen B cell levels assayed by
immunofluorescence. Subsequent Friend Disease Virus infection of drugtreated mice was also used to determine the presence of functional B cells,
Treatment with these four drugs resulted in immune suppression, but
variations in degree, duration, and susceptible cell populations were
noted. Hydrocortisone acetate affected both cellular and humoral
immunity but appeared to have the most profound effect on T cells
involved in expression of DH and induction of antibody production.
Azathioprine and niridazole also caused more pronounced suppression
of T cell rather than B cell function as shown by depression of the
DH response. However, suppression of DH expression was delayed
for several days following azathioprine and niridazole treatment
whereas cortisone suppressed the DH response immediately. Metho
trexate, on the other hand, suppressed the B-cell compartment of
the immune response. Cortisone, azathioprine, and niridazole
appeared to exert their immunosuppressive effect by altering antigen
recognition,either due to defective antigen receptors or unavailable
lymphocytes, whereas methotrexate apparently suppressed lymphocyte
proliferation.
ii
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Chapter 1
INTRODUCTION
Regulation and control of immune responses occupies a major
area of scientific research.

Agents which suppress or prevent

immunological responses, i.e. immunosuppressive agents, aid in
dissecting basic immune mechanisms and are applied clinically
to transplant recipients and to patients with autoimmune diseases,
hormonal imbalance, malignancy, and hypersensitivity conditions.

The

effects of these agents range from indiscriminate bombardment of the
immune mechanisms to specific effects directed at "target areas" (51)•
An understanding of the mechanisms of action of various chemical
and physical agents might enable manipulation to remove undesirable
immune responses without damaging the vital defenses of the host.
However, it must be kept in mind that immunosuppressive agents are
as heterogeneous and complex as the immune reactions which are altered,
although several basic considerations apply to all groups:

hetero

geneity of lymphoid cells, species differences, undesirable sequellae
of elimination of any component of the immune response, and decreased
immunosurvei1lance resulting in increased threat of malignancy and
autoimmune disease.
The immune mechanism consists of several overlapping stages,
predominantly the processing of antigen or afferent arm and the
eliciting of the immune response or efferent arm (20),

Since immuno-

1
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suppressive agents may alter one or more of these processes, a
discussion of the immune mechanism follows.
Antigens entering a host are ingested and processed by macro
phages facilitating immobilization or concentration of these antigens
for easier access to lymphoid cells.

Although the immune system

is composed of two distinct populations of lymphocytes, these cells
originate as precursor bone marrow stem cells capable of responding
to antigen under normal conditions.
One type of lymphocyte is known as thymus-derived or T lymphocyte.
The stem cells migrate to the thymus gland, develop characteristic
surface antigens, and differentiate into cells which function in
cellular immunity.

The T lymphocytes are responsible for defense

against viruses, fungi and intracellular pyogenic bacterial pathogens,
delayed allergic reactions, and surveillance and destruction of malig
nant cells.

These lymphocytes proliferate in the cortical area of

the thymus then shift to the medullary region from where they enter
the circulatory system and peripheral lymphoid tissues as competent
T cells.

During maturation TL isoantigens and the theta isoantigen

arise on the cell surface (l6).

The theta antigen is retained on

cells throughout their circulation and constitutes a T cell marker.
Because T cells are continually circulating and recirculating, the
population may be depleted by such methods as thymectomy, thoracic
duct drainage, or chemotherapy, which will be important in later
considerations of immunosuppressive drugs.
The second component of the lymphoid system consists of Bursaequivalent derived cells or B lymphocytes, which differentiate into
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cells functioning in humoral immunity.

Following antigenic stimulation

through the mediation of a macrophage, B cells differentiate into immuno
competent plasma cells and produce and secrete immunoglobulins,

A

single clone of B cells secretes only one type of antibody and may
be identified by its surface immunoglobulin.

These cells appear to

be localized in the medullary cord, central lymphoid follicles, and
peripheral cortical regions of the lymph nodes, the splenic red pulp
and peripheral wliite pulp, and the subepithelial lymphoid follicles
(51).

Table 1 gives some characteristics of T and B lymphocytes.
Antibody production for certain antigens requires interactions

of the T and B-cell compartments.
"helper” cells and are

Certain T lymphocytes function as

activated by antigen.

These activated T cells

interact with B cells, which in turn produce circulating antibody,
T cell - B cell cooperation may or may not be required for antibody
synthesis.

Antigens such as endotoxin, pneumococcal polysaccharide,

and polyvinylpyrrolidone are T cell independent suggesting that B cells
probably have antigen recognition sites, while sheep red blood cells
(SRBG) and sérum protein antigens are T cell dependent.

Interactions

of the two components tend to amplify the immune response.
Immunosuppressive drugs are used to study the functions of
normal and undesirable immune responses.

Variations in the type of

drug, dosage, and route of administration aid in defining and
dissecting induction and production phases of the immune response,
delayed hypersensitivity and nonspecific inflammatory

responses,

drug induced immunological tolerance, and homograft rejection.
Manipulation of induction and production of the immune response leads
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Table 1.

Comparison of T and B lymphocytes (9).

Properties

B cells

T cells

Tissue origin

Bursa of Fabricius
(in birds) or bone
marrow

Thymus

Cell surface antigen

H-2 transplantation
antigen

Theta
TL

Antigen receptors

Surface immunoglo
bulins

Unknown

Hapten-antigen
recognition

To hapten

To carrier
antigens

Tissue distribution

High in spleen,
low in lymphatic
tissue and blood

High in thoracic
duct, lymph nodes,
and blood .

Functions

Secretion of
antibody

Helper function,
effector cell for
cell-mediated immunity

Complement receptors

Binds C3

None known

Mitogen susceptibility

Pokeweed
Li popolysaccharide

Phytohemagglutinin
Gonconavoline A
Pokeweed

Steroid susceptibility

Resistant

Sensitive

X-irradiation
susceptibility

Sensitive

Resistant

Tolerance

Occurs late, of
short duration

Occurs early, persists
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to an understanding of the multicellular nature of antibody
responses and the differential susceptibility of different cell
populations to drug treatment.
The inductive phase of tlie antibody response is that time between
contact of antigen with the host and antibody production.

Since

low levels of antibody may be beyond detection, the presence of an
inductive phase was questioned,

Sterzl (8?) injected newborn

rabbits with spleen cells and antigen.

When administering 6-mercap-

topurine (6-WP), which substitutes for purines in nucleic acids, with
or shortly following the spleen cell transfer, he noted a marked
decrease in antibody production.
antibody were used,

If donor plasma cells secreting

suppression did not occur, suggesting that the

drug interferes with nucleic acid synthesis in uncommitted lymphocytes,
Gnotobiotic piglets injected with SRBG*s and actinomycin D, which
binds to guanine residues, also show no antibody production, whereas
control animals develop antibodies in three days (88),

Therefore,

induction of antibody formation probably depends on RNA synthesis
leading to mitosis.

In two classic studies by Berenbaum (ll, 12)

irradiation or busulfan given prior to antigenic stimulation inhibited
antibody response to TAB (typhoid - paratyphoid A and B) vaccine in
mice whereas methotrexate (MTX), 6-MP, 6-thioguanine (6-TG), or
nitrogen mustard inhibited the response if given following the anti
genic stimulation.

Evidently, immunocompetent cells are sensitive

to irradiation and busulfan but become susceptible to other immuno
suppressive drugs when differentiated to immunoblasts.
During the productive phase of the primary immune response
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when antibody is being secreted, cells are proliferating and mRNA
is being produced.

When cells in this phase are exposed to metabolic

inhibitors, replication is blocked but antibody production is not
significantly depressed (89).

Sterzl (90) reports that administration

of 6-MP during the primary response has little effect on the secondary
response, but X-irradiation or cyclophosphamide given during the
primary response inhibits the secondary response.

Another interesting

effect of immunosuppression on the productive phase is that low doses
of 6-MP extend IgM production while IgG synthesis is diminished (85).
Turning attention to drug effects on cellular immunity, inter
pretation of immunosuppressive effects on delayed hypersensitivity
depends upon whether suppression is occurring at the level of the
immunological mechanism which is specific and has a distinct induction
period or on the nonspecific level of the inflammatory reaction.

For

example, both MTX and cyclophosphamide block development of primary
contact sensitivity in the guinea pig (99).

However, following passive

transfer of sensitized donor lymphoid cells to drug-treated hosts,
MTX-suppressed recipients elicit a good delayed hypersensitivity
response while cyclophosphamide-suppressed recipients are unable to
evoke a delayed reaction.

Apparently cyclophosphamide affects

both specific and nonspecific phases of cellular immunity and MTX
inhibits only cellular proliferation.

Some drugs such as 6-MP

exert more suppression on delayed hypersensitivity than humoral
immunity (15), a fact which indicates that delayed hypersensitivity
involves a distinct population of cells rather than simply bio
chemical changes in the same population of immunologically reactive
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cells,
l-lany immunosuppressive agents are used to retard the cellular
changes occurring during homograft rejection, hut use of cortisone
during kidney transplants is one of the few treatments of clinical
significance.

Such variability between donor, recipient, and graft

exists that Interpretation of experimental data becomes difficult,
Scothorne (81) finds that cortisone treatment prevents immunoblast
formation and development of granulation tissue in rabbits with skin
grafts while thalidomide effectively suppresses graft rejection if
given to both donor and recipient prior to grafting (102),

These

drugs probably suppress differentiation of the small lymphocyte, the
cell responsible for mediating cellular and humoral immune responses.
The next consideration is the induction of immunologic tolerance
by drugs.

Tolerance is that process in which a host is unable to

respond to a particular antigen but exhibits normal response to
other antigens.

Tolerance may further be subdivided into those

processes in which antigen induces the lack of response and those
in which the immune response is present but masked.

Early work

reports that adult mice infected with lymphocytic choriomengitis
(LGM) resist infection if treatment with MTX in initiated (46),
Schwartz and Dameshek (8^0 also show that tolerance to hunan serum
albumin is induced by giving 6-MP with the antigen.

Tolerance

is specific because antibodies may be produced to bovine gamma
globulin given one month later but not to a second dose of human
serum albumin.

Dose of antigen is extremely critical and not all

antigens are tolerogenic.

Concerning clinical application of drug
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induced tolerance, elimination of antibody secreting cells by drug
treatment may increase the population of tolerant cells.

In this

manner tolerance to a particular antigen may be maintained without
continued administration of drug therapy.
Having briefly considered levels of the immune response which
are subject to suppression, a review of some of the classes of immuno
suppressive drugs will be covered.
into four general categories;

Immunosuppression may be divided

cytotoxic

irradiation, and biologic agents.

chemical, corticosteroids,

The category of cytotoxic

chemicals encompasses alkylating agents, folic acid antagonists,
antimetobolites of purine bases, analogs of pyrimidine bases, anti
biotics, and plant alkaloids.
The cytotoxic agents act nonspecifically by altering basic
metabolic functions in cell division, differentiation, and protein
synthesis.

Their therapeutic usefulness is limited by toxic side

effects, especially the indiscriminate suppression of most stages
of the immune response.

It is interesting to note that depending

on dose and timing, enhanceiu^ivL rather than depression of the immune
response results,

Lance (51) offers possible explanations such as

Lebensraum, increased availability of nucleic acids for replication,
or perhaps feedback of some immune suppressor mechanism.
One of the earliest alkylating agents, nitrogen mustard, was
developed for use in chemical warfare in World War II,

This agent

produces atrophy of lymphoid tissue and was introduced for treatment
of leukemias and lymphomas.

Alkylating agents, typified by nitrogen

mustard, cyclophosphamide, and busulfan are thought to bind to
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electron-rich nucleophilic centers of DMA (especially the N?
of guanine) and protein in rapidly dividing cells such as the
small lymphocytes (83).

These agents form cross links between

DNA-DNA, ÜNA-RNA, ilHA-RNA, DMA-protein, and RNA-protein resulting
in impaired protein synthesis and lymphopenia.

Cyclophosphamide

affects induction of primary and secondary antibody responses as
well as ongoing antibody production if given on the same day as
antigen or several days before (l).

Macrophage ptogocytosis of

carbon particles apparently is not inhibited by cyclophosphamide,
but proliferation of macrophages and antigen retention in the spleen
is decreased (63).

Cyclophosphamide also has a profound inhibitory

effect on development of delayed hypersensitivity if given prior to
the antigen (lOl),

Thus, the effect of alkylating agents is

thought to occur early in the induction of the immune response,
probably at the level of RNA synthesis.

Alkylating agents, though

extremely toxic, have been used clinically for treatment of
leukemias, multiple myeloma, certain types of carcinomas, and
neuroblastoma and experimentally to inhibit development of ex
perimental allergic encephalomyelitis (iCAC) and allograft rejection.
The folic acid antagonists, such as aminopterin and amethopterin
(methotrexate), have limited use in man due to their extreme toxicity,
These agents block the conversion of folic acid to tetrahydrofolic
acid by Inhibiting the action of the enzyme dihydrofolate reductase.
The ultimate effect is inhibition of metabolism of one-carbon units
and eventually synthesis of DMA, RNA, and proteins.

Methotrexate

also blocks differentiation of immunoblasts into small lymphocytes
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by selectively depressing dehydrogenase activity (30),
the effect of methotrexate may be reversed by

Interestingly,

administering large

doses of folinic acid, thus reducing toxicity while maintaining
immunosuppression.

Folic acid antagonists cause remarkable

suppression of primary and secondary antibody induction, (?3 antibody
selectively), if given within 24 to 48 hours following antigen or
within 72 hours prior (80,98),

However, methotrexate is ineffective

in suppressing ongoing antibody synthesis.

Cell-mediated immune

responses such as delayed hypersensitivity to tuberculin and
contact sensitivity to oxazolone may also be abolished by folic
acid antagonists if the drug were administered within four days
following sensitization (lOl).

Reconstitution of drug treated

mice with cells of sensitized donors confers delayed type sensitivity.
Other cell-mediated immune responses such as graft versus host
reaction and allograft rejection are also suppressed by these
agents.

Folic acid antagonists probably inhibit DNA selectively

since iiuaunoblasts develop normally, but development of specific
populations of small lymphocytes is blocked even if given after
onset of the disease (lOO),

Methotrexate is used experimentally in

suppressing LGM infection in mice and EAE in quinea pigs and rabbits.
Clinically, methotrexate is accepted for treatment of severe
psoriasis, some carcinomas and leukemias, and uveal disease.
The antimetabolites of purine bases, characterized by 6-MP,
6-TG, and azathioprine (Imuran), are synthetic substances which
interfere with the biosynthesis of nucleic acids by competing with
the nitrogen bases adenine and quanine.

Suppression of the ?S
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primary antibody response to the intracellular parasite Listeria
monocytogenes is accomplished by administering antigen and azathioprine
on the same day.

However, 193 antibody is not suppressed and may

even be enhanced (98).

In contrast, azathioprine has no effect on

passive transfer of cell-mediated immunity.

Mice protected with

immune lymphoid cells to Listeria monocytogenes did not succumb
to infection when given the drug on the day of immunisation or 24
hours prior to passive immunisation (97).

Apparently, azathioprine

is not effective against immunologically active cells but may be
restricted to suppression of the inductive phase of immunity.
This drug is used extensively in both clinical and experimental
suppression of allograft rejection of kidneys, hearts, and livers,
especially in combination with other immunosuppressive regimens.
Recent use of azathioprine in treatment of systemic lupus
erythematosus and glomerulonephritis reveals arrest of the diseases
with subsequent suppression of the inflammatory response.
Analogs of pyrimidine bases are mainly used 3^ vitro to
study the secondary antibody response.

The chemicals ^-bromo-

deo^yuridine (BUDR) and ^^fluoro-uracll deoxyriboside (FUDR)
are important carcinostatic and virostatic agents which replace
uracil and result in the synthesis of abnormal DMA,

Cytosine

arabinoside and 6-azauridine inhibit DNA polymerase and are incor
porated into DMA and RNA,

Experiments with FUDR treatment in

cancer patients reveal inhibition of primary antibody response in
80?o, suppression or delay of secondary response in about 40>î, and
depression of delayed hypersensitivity to skin sensitizing antigens
(60),

Cytosine arabinoside affects macrophage differentiation.
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inhibits ?S antibody production, mainly in vitro, and markedly
suppresses cell-mediated immune responses (4^).
Use of antibiotics as immunosuppressants is confined mostly to
in vitro studies.

To cite a few, the actinomycins bind to quanine

residues of DMA and interrupt DHA directed RUA synthesis.
Chloramphenicol inhibits bacterial protein synthesis by binding to
mRHA and by suppressing the activity of peptidyl transferase (39).
The antibiotics may interfere with the humoral response either by
inhibition of antibody synthesis, by interaction with mRlïA or
tRHA, or by alteration of the genetic code.
The plant alkaloids deserve mention because of their use in
combination chemotherapeutic regimens.

Such agents as vincristine

and vinblastine, derivatives of the periwinkle plant, and
colchicine, an extract of the autumn crocus, block spindle
formation during metaphase of cell mitosis.

In addition colchicine

probably inhibits phagocyte digestion of foreign particles.

The

vinca allcaloids suppress antibody response and DH if given with
or after antigenic stimulation (56) whereas colchicine is only
effective in suppressing antibody response,
Niridazole (Ambilhar), a now anthelminthic drug introduced in
1964, is used in the treatment of schistosomiasis.

The agent is a

nitrothiazole derivative 1-(5-nitro-2thiaaolyl)-2“imidazolidinone,
The drug is apparently concentrated in adult worms and inhibits
phosphorylase activation, resulting in decreased glycogen levels in
the schistosomes (43).

I%Lhmoud and Uarren (54) report remarkable

suppression of cell-mediated immunity by niridazole resulting in
reduced schistosome egg granuloma and delayed footpad swelling to
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soluble egg antigens.

In addition, niridazole is more effective in

maintaining allograft survival to strong histoincompatibility antigens
than other immunosuppressive agents currently used in organ trans
plantation (55)•

Furthermore, niridazole apparently lacks the

toxic side effects of other immunosuppressants.

Decrease in white

blood cell counts, bone marrow, or increased susceptibility to
infection are not noted (41,06).

The mechanism of action of

niridazole is not understood but may involve suppression of non
specific inflaiOJTiatory reactions (72).

Influence of this drug on

Immoral immunity has not been extensively studied, but a recent
report indicates tliat continued niridazole therapy depresses
antibody production (6?).
It is noted earlier that immunosuppression may affect one or
more phases of the immune response, from antigen processing,
through cell differentiation and proliferation, and eventually
antibody secretion and actions of sensitized cells.

Glucocor-

ticosteroid hormones are thought to liave the unique attribute of
affecting each stage of the immune response.

These are the most

commonly used drugs for the suppression of undesirable immune or
inflammatory responses, especially with regard to homotransplantation.
Even though clinical application is extensive, considerably less is
known about the cellular responses through which the effects occur,
Uhen interpreting data with corticosteroids, species differences
must be kept in mind.

Mouse, rat, hamster, and rabbit appear to be

steroid-sensitive while man, guinea pig, and monkey are relatively
steroid-resistanb (23).

The exact basis for these differences is

unknown.
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One of the effects of corticoids is upon peripheral leuko
cyte populations.

Transient but selective decreases in circula

ting lymphocytes and monocytes and an increase in neutrophils
occur in man within four to six hours following corticosteroid
therapy but these cells return to normal levels within 24 hours
(36, 71).

Circulating T lymphocytes decrease, probably as a result

of redistribution to other areas of the body (26,34,35,108).
During the period of lymphocytopenia functionally mature lympho
cyte subpopulations are detected in the bone marrow, even though
total numbers of bone marrow lymphocytes remain constant.

Therefore,

the bone marrow assumes increased immunocompetence while the
circulating lymphocyte population becomes immunosuppressed.
Corticosteroids also have an influence on the humoral immune
response.

Corticosteroids are used to control some of the symptoms

associated with IgG and IgM humoral antibody responses in certain
allergic and autoimmune diseases.

It is reasonable to ask

whether corticoids prevent induction and/or expression of the immune
response and what cell types are affected.

Administration of

methylprednisolone to human volunteers results in decreased
IgG and IgA but no significant decrease in IgM levels (17).

It

was shown by studies with ^^^I-IgG that corticosteroid-induced
decreased IgG synthesis accounts for 90% of the decrease in serum
IgG levels.

Increased catabolism of IgG accounts for the

remaining 10%.

Cohen (25) repopulated lethally irradiated mice

with bone marrow and either normal or hydrocortisone-treated
thymus cells.

Mice in both groups mounted equal antibody responses

to SRBC’s, which is surprising since thymus glands of cortisone-
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treated mice contain only

of the lymphocytes normally present.

This suggests that 5:^ of the thymus lymphocytes which are corti
costeroid-resistant are also immunocompetent.

Antibody production

by spleen cells, a function of T and B cells, is suppressed but
may be restored by administration of bone marrow cells of normal
mice.

The B cell precursor thus appears to be the corticosteroid-

sensitive step in induction of humoral immunity,

Cohen finds

mature antibody secreting cells to be corticosteroid-resistant.
In contrast, Butler (l?) reports that human volunteers on methyl
prednisolone therapy develop high levels of circulating antibody
to keyhole limpet hemocyanin, diphtheria toxoid, tetanus toxoid,
adenovirus vaccine, and influensa-virus vaccine, even though
total IgG serum concentration decreases.

lie also notes that

naturally acquired herpesvirus titers drop, indicating inhibition of
ongoing antibody synthesis or expression of humoral immunity.
Corticosteroids may also alter cell-mediated inununity such
as delayed hypersensitivity, contact sensitivity, allograft
rejection, and graft versus host (CVIl) reaction.

These pheno

mena are regulated by T lymphocytes which contact specific antigen
and are stimulated to divide and secrete soluble factors.

The

visible inflammatory lesion is a result of localization of i.onspecific cellular elements.

Corticosteroids inhibit the Inflammatory

response,but is it at the level of the lymphoid initiator cell
or the ensuing nonspecific response?

In order to discuss the

differential sensitivity of T cells, it is necessary to consider
each of the T Cell functions.

It lias already been pointed out that
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all but 5/» of the thymus lymphocytes are corticosteroid-sensitive,
but the remaining cells manifest inununocompetence in eliciting GVH
and helper cell function in lethally irradiated hosts.

Cohen (25)

establishes that hydrocortisona inhibits the GVH reaction.

He

transfers parental strain lymphoid cells, control and hydrocortisonetreated, to F^-hybrid hosts and notes enlarged spleens in only
animals receiving control lymphoid cells.

Parental lymphocytes

apparently home to the recipient's spleen and are stimulated to
divide by histoincompatibility antigens.

These stimulated donor

cells release factors which result in proliferation of the recip
ient's cells and also in a nonspecific inflammatory response to
injury.

Spleen and thymus cells of hydrocortisone-treated parental

donors, however, do

not protect Fj-hybrids from the GVH reaction.

Therefore, he postulates that hydrocortisone suppresses the non
specific inflammatory response and not the T cells initiating
the GVH reaction.

In contrast to the steroid resistance of T

cells activated by antigen, T cells activated by the nonspecific
mitogen phytohemagglutinin (PHA) are corticosteroid-sensitive
(13,19,36).

After activation by antigen or mitogen, T lymphocytes

affect other cells via direct cell contact or through the production
of soluble mediators.

Little is known about the

vivo effects of

corticosteroids on lymphocyte-produced mediators of cellular immunity.
According to Williams and Granger (IO5 ) corticoids inhibit PIIAinduced lymphotoxin production by human lymphocytes.

Furthermore,

macrophage migration intiibitory factor (MIF) is released by
lymphocytes of corticosteroid-treated guinea pigs, but macrophages
of these animals are unable to respond to MIF.

Thus, steroid hormones
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appear to interfere with the effector limh of lymphocyte mediator
function.

In summary, figure 1 shows the differential sensitivity

of lymphoid subpopulations to corticoids.
Considerable work has been done to elucidate the mechanism of
glucocorticoid action.

Recent work suggests tliat physiological

responses to steroid hormones are mediated through specific
intracellular protein receptors (lO),

Steroids penetrate the

membrane and bind to the receptors inside the cell.

Loss of

receptor correlates with loss of steroid sensitivity.

Steroid binds

with the receptor, which probably undergoes a conformational
change allowing close association of the recepkor-steroid complex
with DIIA,

Accumulation of mRNA then occurs, but the mechanism does

not explain the exertion of an inJriibitory effect by glucocorticoids
during increased RNA synthesis.
Whole body irradiation by X-irradiation is one of the
earliest forms of immunosuppression.

Inhibition of antibody

response and suppression of graft rejection can be accomplished by
administration of X-ray prior to injection with antigen.

The

treatment destroys lymphocytes and stem cells but also damages
severely other hematopoietic and tissue cells.

Local application

of irradiation to tumors or grafted skin or organs reduces the
toxicity problem but also limits the contribution of X-irradiation
as an immunosuppressant (51).
A variety of biological agents and surgical treatments are
also available for suppression of the iffonunc response.

Anti

lymphocyte serum is a potent inhibitor of cellular immunity and
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Figure 1.

Fluctuation of sensitivity and resistance of lymphoid
cells to cortisone (23).
res: resistant to cortisone
sens: sensitive to cortisone
ag: antigen

res
medulla
sens
cortex

res

res

Activated
T cell

ag
mi tog

Effector
mechanisms
sens?

sens
THYMUS
res
T cell

B cell
sens
ag

BONE MARROW

precursor

sens?

" marrow
lymphocyte

Activated
B cell
res

Antibody
res

res

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

19
does not produce the toxic side effects of other immunosuppressive
agents (75).

Antilymphocyte serum binds to the recirculating

population of antigen-reactive cells, which are then eliminated by
cytotoxic destruction.

Humoral inunune responses to T-cell-dependent

antigens may also be decreased by antilymphocyte serum.

Specific

elimination of cellular immunity by this antiserum increases the
possibility of lowered host resistance and generation of spontaneous
neoplasms.

Viral infections with non-oncogenlc (68) and oncogenic

(74) viruses may cause immunosuppression of either compartment of
the immune response.

Surgical removal of thymus, spleen, or lymph

nodes may result in depletion of specific populations of cells.
The opportunities for Immunosuppression, table 2, range from
specific to nonspecific, physical, chemical, and biological agents.
Variations in dosage, schedule, and route of administration may
result in suppression of virtually every phase of cellular and/
or humoral immunity.

However, the immune responses most affected

by the nonspecific immunosuppressive agents are listed in table 3 .
Statement Of The Problem
Pour drugs are used in this study;

hydrocortisone acetate,

aaathioprine (Imuran), niridasole (Ambilhar), and amethopterin
(Methotrexate).

These drugs are classified as corticosteroid,

purine antimetabolite, cytotoxic chemical, and folic acid antago
nist respectively.

Immunosuppressive drugs are used extensively

although their effects on the imiaune system are poorly understood.
For this reason, this study was designed to investigate the
temporal response of a variety of immunosuppressive drugs on the
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Table 2,

Immunosuppressive agents (nonspecific),

Physical af^ents

Irradiation

Chemical agents

Alkylating agents
Purine analogs
Pyrimidine analogs
Folic acid antagonists
Antibiotics
Plant alkaloids
Carcinogens

Biological agents

Enzymes
Hormones
Antilymphocyte serum
Antimacrophage serum

Living organisms

Viruses
Parasites

Removal of lymphoid
tissue

Thymectomy
Splenectomy
Bursectomy in birds
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Table 3»

Compartments of the Immune response most affected
by various immunosuppressive agents.
Ap;ent

a

)

Cytotoxic chemicals

Compartment
humoral

alkylating agents
antimetaboli tes
folic acid antagonists
antibiotics
plant alkaloids
B)

Corticosteroids

C)

Irradiation

D)

Biologic agents
thymectomy
antilymphocyte serum
ensymes
bursectomy

Cell-mediated
Humoral

Cell-mediated
Cell-mediated
Cell-mediated
Humoral
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T and B lymphocyte compartments of the immune response using
the mouse system as a model.

Understanding mechanisms of

action may px-ovidc a rational basis for immunosuppressive therapy,
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Chapter 2
i-LfVTCRIALS and MlîTliODS
Animal;
Male Cwlss-’
iebster mice were obtained from a colony main
tained by Rocky Mountain Laboratory, Hamilton, Montana.

Mice

used for all investigations were five to six weeks of age.
Drugs
Hydrocortisone acetate (Microfine), Towne, Paulsen, and Co.,
Inc. Monrovia, California 91016, was suspended in cortisone diluent
(Table 4) to concentrations of 10 mg/ml, 20 mg/ml, or 40 mg/ml.
Mice wore injected subcutaneously in the nuchal area with I50 mg/kg,
350 mg/kg, or 600 rag/kg body weight.
Imuran^ brand azathioprine, Burroughs Wellcome Co., Research
Triangle Park, Morth Carolina 27709, ifas dissolved in O.83/
sterile saline to a concentration of 10 mg/ml.

Mice were injected

subcutaneously in the nuchal area with I50 mg/kg body weight,
I.'lx'idaaolc, Ciba Ptiarmaceutical Co., Division Ciba-Geigy
I

Corp. , Gummlt, Hew Jersey 07901, ifas suspended in sterile
distilled water to concentrations of 2 mg/ml and 20 mg/ml.

The

drug was administered orally by using a 1 ml syringe with attached
beveled and bent (45^ angle) I6 gauge needle which could be inserted
deep into the animals throat.
Methotrexate, Lederle Labs, Division, American Cyanamid Co.,
Pearl River, Hew York 10905» was dissolved in 0.5 M sterile Ka2Cû^
to a concentration of 40 mg/ml.

Mice were injected intraperitoncally

23
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with 250 mg/kg body weight.
All di'ugs were administered 10, 0, 6, 4, 2 or 1 day prior
to antigen or on the day antigen was administered.
Humoral Immune Response by Hemagglutination
Rabbit blood was obtained from an adult New Zealand white
rabbit by cardiac puncture.

Equal volumes of Alsevers solution

(Table 5) and blood were mixed and allowed to equilibrate for 40
hours.

Cells were washed three times with 0.8^^ saline and

centrifuged at I5OO rpm on a Universal centrifuge Model V for
five minutes each time.

Red blood cells were resuspended in

0.B5:’5 saline to a concentration of 2.5'/’^.

Mice were immunized

intravenously via the tail vein with 0,2 ml of the
red blood cell suspension using five mice/group.

rabbit
Mice were bled

from the axillary artery five days later, and serum vfas collected.
All sera were heat inactivated at ^6°C for 30 minutes.

Hemagglu

tination was performed on serial two-fold dilutions of serum by
the microtiter method with the materials of Cooke Engineering Co.,
Alexandria, Virginia.

Rabbit red blood cells were washed three

times with 0.35/J saline and resuspendcd to a concentration of 2,a
in 1% normal rabbit serum, which was prepared in saline.
was 1/0 normal rabbit serum in saline.

Diluent

The reaction was incubated

at 37^0 for one hour then overnight at room temperature.
Delayed Hypersensltivity (üil) Response by Oxazolone Sensitization
According to the method of Asherson and Ptak (2 ), seven mice/
group ifere sensitized prior to or following drug administration by
applying 3:^ oxazolone (4-Ethoxyinethylene-2-phenyl oxazolone) 3OH
laboratory Reagents, BDH Chemicals Ltd., Poole, England, in
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absolute ethanol to the preshaved abdomen using 0,1 ml/mouse.
The solution was rubbed in with the lengthwise edge of a 20 guage
needle.

Seven days following the final day of drug treatment or

oxazolone sensitization, 2,j oxazolone in absolute ethanol: olive
oil (l;l) was applied to both ears of sensitized mice, 1 drop/ear
delivered from a 25 gauge needle.

The emulsion was rubbed in

extensively with a cotton tipped applicator stick.

Skin tests

were read at 24 hours by measuring double ear thickness with a
Schnelltaster,

Results were reported as group averages and percent

of control ear thickness,
1‘
V iend Disease Virus Infection of Drug Treated Animals
Friend Disease Virus (PDV) was obtained from the Stella
Duncan Research Institute, University of Montana, Missoula,
Montana,

The institute prepared stock pools of the virus after

three passages were made in 3wiss-iiebster mice at The Rocky
Mountain Laboratory, Hamilton, Montana,
To prepare working stock suspension, 30 male mice were in
jected with 0.2 ml of 10

dilution of FDV,

After 28 days the

mice were sacrificed and the spleens were removed and suspended
in cold medium, consisting of chemically defined Medium 199 (m-199),
GIBCO, Grand Island, Hew York, and diluted to a concentration of
20'^.

After teasing the tissues over a wire mesh and placing into

two 40 ml plastic centrifuge tubes, the suspension was centrifuged
at iCOO rpm in an RC-2 Sorvall refrigerated centrifuge for 15
minutes at 4®C,

The supernatant was then collected and centrifuged

at 6000 rpm for 30 minutes at 4°G,

The top 2/3 to J>/h of the clear

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

26

supernate was removed and pooled.

Aliguots of 0.6 ml were

distributed in 2 ml ampoules, sealed, and frozen in a Revco
freezer at -70^C.
Following drug treatment, mice were injected intravenously
with 0.2 ml of a 10

dilution of FDV using 10 mice/group (96).

On day 14 all animals were weighed and autopsied.

Spleens were

removed, weighed, and fixed in Bouin's fixative (Table 6).

Viral

plaques were counted after 18 hours fixation, according to Axelrad
and Steeves (3).
Blood Cell Counts and Differentials
Blood was collected from the axillary artery of drug treated
mice.

Whole blood was diluted 1:500 with 0.85% saline for red blood

counts and 1:20 with Turk's diluting fluid (Table 7) for leukocyte
counts.

Counting was accomplished using a Neubauer hemocytometer.

Differential leukocyte counts were performed on blood smears
stained with Giemsa (Table 9).
Immunofluorescence
Drug-treated mice were sacrificed and their spleens immediately
placed in cold m-199 plus 10% Fetal Calf Serum and 10% triple dis
tilled water containing five units preservative free heparin/ml.
Spleens were teased through a wire mesh into 10 ml cold media.
The cell pellet was resuspended in 10 ml cold media and layered over
10 ml of Ficoll-Hypaque (Table 8) in 40 ml Sorvall centrifuge tubes.
o
Centrifugation was carried out at 1500 rpm for 20 minutes at 4 C
in an International portable refrigerated centrifuge model PR-2.
The white lymphocyte layer was removed and washed three times in
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cold, media.

Lymphocytes were counted using a Neubauer hemocyto-

meter and were resuspended in media to a concentration of ^ X 10
cells/ml.

Cells (O.l ml) were placed in Corning centrifuge tubes

(2 mm X 30 mm) and 0.1 ml of a 1 :4 dilution of mouse anti-serum
globulin (rabbit origin) conjugated with fluorescein isothiocyanate
(Pirc), Colorado Serum Co., 4950 York Street, Denver, Colorado,

was added.

All tubes were incubated for 45 minutes at 4°C.

Following

incubation cells were centrifuged at 1200 rpm for one minute and
washed three times with 0,4 ml cold media.

Lymphocytes were

resuspended in two drops of media and placed on a glass slide with
cover slip.

Paraffin was used to seal the edges of the cover slip.

All slides were viewed using a Zeiss fluorescence microscope with
excitation filters 1 and III and barrier filters 50 and 0,

A

total of 200 cells/slide were counted, fluorescent cells being
scored as B cells and non-fluorescent cells as T cells.

Cells

showing diffuse fluorescence rather than strictly membrane
fluorescence were considered nonviable and were not counted.
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Table 4.

Cortisone diluent.

Saline 0.85^

98.7 ml

Tween 80

0,4 ml

Nutritional Biochemical Corp.

Benzyl Alcohol

0,9 ml

J.T. Baker Chemical Co.

Carboxy methyl cellulose

0.5 g

Svenka Cellulosa AB
Sundsvall, Sweden

Add in order given.

Table 5#

Alsevers solution.

Dextrose

20.5 g

Sodium citrate (dihydrate)

8.0 g

Citric acid (monohydrate)

0.55 g

Distilled water

to 1 liter

Dissolve ingredients successively in distilled water. Autoclave
at 15 psi for 15 minutes. pH should be 6.1. Use 1 part bloodt
1 part Alsevers.

Table 6.

Bouin's fixative.

Picric acid (saturated aqueous, filtered)

73 ml

Neutral formalin (filtered)
20 g sodium acetate plus 100 ml 40g( formalin

25 ml

Glacial acetic acid
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Table 7.

Turk's white blood cell diluting fluid,

Glacial acetic acid

2 ml

Aqueous gentian violet IfC w/v

1 ml

Distilled water

100 ml

Mix and filter.

Table 8,

Picoll - Hypaque.

1.

Dissolve 9.34 g sodium diatrizoate, Winthrop Laboratories,
90 Park Ave., New York, New York 10016, in 30 ml distilled
water and adjust to pH 7.3.

2.

Add 72 ml distilled water.

3.

Dissolve 6.28 g Ficoll, Pharmacia Pine Chemicals AB,
Uppsala, Sweden, in above solution.

4.

Encase bottle in foil and autoclave for 15 minutes at 121*0.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

30

Table 9.

Giemsa stain for mouse blood cells.

Stock giemsa:

1.

Dissolve 0.5 g giemsa powder in 33 ml glycerine.

2.

Heat at 55 - 60°C for Ih to 2 hours.

3.

Add 33 ml absolute methanol.

0.15 M phosphate buffered saline pH 6.4:
0.85% saline

(PBS)
100 ml

0.15 M Na^HPO—
2
4

32.2 ml

0.15 M KHgPO^

67.8 ml

1.

Fix smears in absolute methanol for 10 seconds or longer.

2.

Allow slides to air dry.

3.

Rinse a small test tube with 5 ml distilled water and add
another 5 ml distilled water to the tube. Add a few crystals
of hematoxylin to the test tube. If the water appears yellow the
pH must be adjusted. Add about 0.1 ml 1% KCO^/ 200 ml
distilled water. The color of the water in tne 5 ml tube
should be light pink in color when hematoxylin is added.

4.

Use 0.2 ml stock giemsa/ml PBS pH 6.4.
3 ml/slide for 30 seconds.

5.

Float off stain with adjusted distilled water.

Flood smear with
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Chapter 3
RESULTS
Hydrocortisone Acetate
The initial experiments were designed to investigate the
temporal effects of cortisone on humoral and cell-mediated im
munity.

In general cortisone markedly diminished both components

of the immune response for four days following drug administration.
Administration of antigen shortly after administration of drug
resulted in a decrease of circulating antibodies to rabbit red
blood cells (Figure 2).

Increase in time intervals between drug

txreatment and antigen administration effected a recovery of the
antibody response which was apparent by day 10.

There were no

significant variations in the antibody titer of groups of mice
receiving different doses of hydrocortisone acetate.

Since red

blood cells are T-lymphocyte-dependent antigens, it was not
possible to determine idiether suppression occurred at the level
of the T-cell precursor, B-cell presursor, or both.

Therefore,

the experiment was repeated using the T-cell-independent antigen
lipopolysaccharide.

With this antigen, a decreased antibody

titer was noted only one or two days following cortisone treatment.
The ability of mice sensitized to oxazolone and treated with
cortisone to express a delayed reaction was studied.

This ability

to express a OH response was essentially abolished during the first
four days following cortisone treatment but gradually increased to
31
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control levels by day 10 (Figure 3).

While the pattern of

reaction was similar in mice given different doses of cortisone,
recovery was much less in those given larger doses of drug.
However, if mice were given cortisone and then sensitized with
oxazolone in order to determine the action of drug on the
afferent arm, the initial lack of DH at day zero was followed
by gradual increase in skin sensitivity culminating in marked
enhancement of the DH at day 4, after which the response declined
and approached control levels (Figure 4).

Skin tests were repeated

on the oxazolone pre-sensltlzed mice between ten and twenty days
following cortisone treatment and from 30 to 60^ recovery of the
DH response was noted.

The nonspecific inflammatory response was

eliminated as shown by the absence of inflammation in ears of
skin-tested hydrocortisone-treated mice.

Both the affeetor and

effector arms of the DH reaction were disturbed in mice treated with
cortisone but to different degrees at various times after admin
istration of the drug.
The weight of the spleens of drug-treated mice showed a
remarkable decrease through day 4 and was followed by a gradual
Increase which was less apparent in mice given the larger doses
of cortisone (Figure 5)»

The w e i ^ t of spleens of control mice,

however, always increased in size with age.
Interestingly, cortisone-treated mice (l50 mg/kg) were as
susceptible to FDV infection as control mice (Figure 6).

Other

investigators (21,?6) have noted that mice with suppressed humoral
immunity do not exhibit increased spleen weights or spleen viral
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foci (plaques) idiich are quantitative measurements used to detect
PDV Infection.

This may suggest that hydrocortisone Immunosuppression

Is directed against the T-lymphocyte precursor rather than the
B-lymphocyte precursor.
mice appeared confusing.

Data from the 350 mg/kg cortisone-treated
Viral foci were nearly confluent In

spleens of all Infected mice, but spleen weights fluctuated con
siderably.

Spleen sizes of Infected mice Increased over control

spleens If FDV was given one or two days following cortisone
treatment, decreased rapidly when FDV was administered four days
following drug treatment, and gradually Increased at time Intervals
thereafter.

Generally, spleen size and plaque number correlate

well, whereas In this experiment spleen weight was low even trtille
spleen plaque numbers were high.
Spleen B cell populations were assayed by Immunofluorescence.
Data was difficult to obtain during the first days Immediately
following drug administration because of the drastic reduction In
spleen size.

However, on the basis of other sampling Intervals

total spleen B cell populations appeared only minimally depressed
throughout the course of treatment (Figure 7).
In order to determine the effect of different doses of
cortisone on populations of perl|dieral white blood cells, total
white and red blood cell counts and differentials were performed.
Variations for total red blood cell counts were within normal ranges
In all cases.

Total white blood cell counts of mice treated with

150 mg/kg cortisone fluctuated around the lower range of counts
for untreated controls.

Mice treated with 350 mg/kg cortisone

had counts lower than normal for the first two days, peaked
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sharply on day 6, and then gradually declined.

Leukocyte

responses of mice treated with high doses of cortisone (600 mg/kg)
closely resembled those of mice treated with the intermediate dose.
Relative to the total white blood cell count, neutro^il numbers
were elevated t h r o u ^ the fourth or sixth day in all cortisonetreated groups and then started a gradual decline (Figure 8).
Lym]^ocyte numbers dropped through day 6 and then began a gradual
recovery.
treatment.

Monocyte levels remained depressed throughout cortisone
These selective alterations in leukocyte populations

agree with data obtained from humans on corticosteroid therapy (36),
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Figure 2.

Effect of hydrocortisone acetate (administered on day
zero) on the humoral immune response of mice to rabbit
red blood cells. Each point represents pooled sera of
five mice. HA = hemagglutination titer.
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Figure 3.

Effect of hydrocortisone acetate (administered on day
zero) on the DH response of mice previously sensitized
with oxazolone. Each point represents pooled measurements
from both ears of seven mice.
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zero) on spleen weights of treated mice.
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point represents the mean of the results from ten mice.
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Aaathioprine
Based on experiments conducted in this study, immuno
suppression by azathioprine was not particularly impressive.
Humoral antibody responses as measured by hemagglutination of
rabbit red blood cells were depressed by only one 2-fold dilution
when drug was given either on the day of rabbit red blood cells or
one day prior to antigen (Figure 9).

A sharp peak occurred when

drug was given eight days prior to antigen.

These results were in

agreement with those of Tripathy (98) who found that production of
19S antibody to Listeria monocytogenes was not suppressed and, in
fact, appeared to be enhanced.
There was a heightened DH response to oxazolone on the eighth
day following drug treatment in mice previously sensitized with
this agent (Figure 10).

The other deviation observed was de

pression of the DH response between four and six days following
administration of the drug.

Since azathioprine interferes

primarily with induction of immunity, lymphocytes sensitized to
oxazolone prior to drug treatment were present and functional
several days following challenge with azathioprine.

Depression of

DH at day 4 may indicate that azathioprine eliminates some of
these oxazolone-sensitized lymphocytes.

Apparently compensation

by production of more sensitized cells is manifested by day 8
following drug treatment.
Susceptibility of azathioprine-suppressed mice to PDV was
decreased when FDV was given within two days following drug treat
ment but compared closely with control animals thereafter (Figure ll)
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Apparently B cells are Important for viral replication and
intervals of suppression of humoral immunity correlated with
decreased spleen w e i ^ t and plaque numbers during FDV infection.
Spleen weights of drug-treated mice revealed no variation from
control spleen weights except for a sharp peak in w e i ^ t at day 6
(Figure 12).

Hiis rise may correlate with B cell increase

during peak antibody titer and depressed DH at this time.
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Figure 9.

Effect of azathioprine (150 mg/kg administered on day
zero) on the humoral immune response of mice to rabbit
red blood cells. Each point represents pooled sera of
five mice. HA = hemagglutination titer.
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zero) on susceptibility of mice to FDV infection. Each
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Nlrldazole
The Immunosuppressive potential of niridazole, which is
relatively nontoxic, was investigated because of repoirts citing
marked suppression of DH to soluble schistosome egg antigens (54)*
Antibody titer to rabbit red blood cells was decreased by only
one 2-fold dilution throu^out the interval of drug treatment,
which can hardly be considered a suppression of the humoral
immune response (Figure 13).

Recently humoral immune suppression

by niridazole was accomplished by eight days of continued drug
therapy (67).

One dose of d m g produced no noticeable suppression.

The DH response of mice previously sensitized with oxazolone
was depressed only slightly between the fourth and sixth days
following administration of the drug (Figure 14).

However, on

the eighth day remarkable etüiancement of the delayed response
occurred with both high and low doues of drug.
Susceptibility of mice to FDV was not altered by niridazole
treatment (Figure 15)* a result supported by the fact that
humoral immunity was not depressed.

Similar to azathioprine-

treated mice, spleen weights of niridazole-treated mice peaked
during the time of depressed IHl (Figure l6).
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Methotrexate
The folic acid antagonist methotrexate exhibits considerable
toxicity and causes suppression of the humoral immune component
of the Immune system.

Hemagglutination titers to rabbit red blood

cells were depressed during the entire ten day interval following
drug treatment (Figure 1?).

In close agreement, susceptibility to

FDV was nearly abolished when methotrexate and FDV were given on
the same day (Figure 18).

Thereafter, susceptibility to infection

Increased to levels comparable to controls suggesting that B
lymphocyte recovery occurred well before recovery of antibody
production.

A decrease in the population of B lymphocytes in the

spleen as assayed by immunofluorescence (Figure 19) correlated with
the depressed antibody titer.

Spleen w e i^ t s of drug-treated

mice did not vary significantly from controls (Figure 20).
Satisfactory data on the effect of methotrexate on the delayed re
sponse to oxazolone was not obtained.
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Effect of methotrexate (250 mg/kg administered on day
zero) on B cell populations in spleens of mice as assayed
by fluorescent antibody.
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Chapter 4
DISCUSSION
Studies of immunodeficiency diseases, the effects of surgical
removal of lym^diold tissues, and Immunosuppression by drugs have
aided In separating the two lymphoid cell populations Involved In
the Immune response.

The B lymphocytes are the antibody-producing

cells of the humoral Immune system, and the T lymphocytes function
as helper cells for antibody production to certain antigens and
as mediators In cellular Immune responses.

The T and B cells of

animals treated with Immunosuppressive drugs during Induction of
the Immune response differ In their sensitivity to various drugs.
Therefoire, such drugs may affect natural resistance as Is evidenced
by decreased resistance to Infections and tumors In Immunosuppressed
hosts.
In this study the temporal effects of four drugs on the
humoral and/or DH response are Investigated.

The major emÿkasls

Is placed on determining the effects of hydrocortisone acetate.
Minimal studies with azathioprine, niridazole, and methotrexate
are Included as a general reference to determine whether all of
these Immunosuppressive drugs alter the Immune system In a similar
manner.
Expression of DH
The effect of cortisone on the afferent and efferent arms
58
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of the delayed response to oxazolone differs with respect to the
response at various intervals after administration of the drug.
Following the administration of cortisone, expression (efferent
arm) of the already established delayed reaction to oxazolone
is almost wholly depressed for a period of four days.

After an

additional two days, the capability of mice to respond to a
sensitizing dose partially returns, but complete recovery is not
noted until the tenth day.

These results suggest several possible

effects of cortisone on committed T cells and/or perhaps only on
innocent-bystander lymphocytes which are necessary for committed
T cells to effect a lesion at the skin test site.

One possibility

m i ^ t be that the T cells are directly affected by cortisone and
are unable to respond to an eliciting dose of antigen.

Another

is that some mechanism acts to prohibit migration of the committed
cells from the immune cell "reservoir".

Lastly, the T-cells

may be distributed to other body compartments and become un
available for expression of 1*1.
The effect of azathioprine and niridazole upon the efferent
arm of the DH reaction does not follow the course observed with
cortisone.

There is a slight increase in the response on the day

following administration of either of these drugs, and on day four
and six the response is suppressed.

In contrast to the gradual

recovery noted in cortisone-treated mice, the response returns to
normal or above normal levels in two days.
The mechanism of depression of T cell activity produced by
treatment with azathioprine or niridazole may be qualitatively
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different than that produced by administration of cortisone.

It Is

essential, however, to point out that cortisone Is administered In
a carrier which serves to cause a slow releaise of cortisone from
a depot resulting In a prolonged clearance of the drug from the
animal.

If mice are Injected with cortisone alone, the length of the

depressed state may be as short as that caused by azathioprine and
niridazole.

Furthermore, In the form administered, azathioprine

and niridazole may be Inactive chemically.

The means whereby

these drugs exert their effect may differ since cortisone may exert
Its effect directly on lymphocytes while azathioprine and niridazole
require chemical alteration In order to exert their depressive
properties.

The recovery of the M

response would, therefore,

occur more abruptly since altered chemicals may be rapidly
eliminate!from the animal.

Additional studies on the status of

circulating lym^Aiocytes following administration of azathioprine
and niridazole hopefully will provide Insight Into the similarities
or differences between these drugs and cortisone.
Induction of DH
In the Induction (afferent arm) studies, separate groups of
mice are treated with cortisone at various Intervals during a
ten-day period and sensitized with oxazolone on the final day of
drug administration.

After an additional seven days the contact

sensitivity assay is performed.

In animals given cortisone two

days before or at the time of exposure to oxazolone, the DH response
Is depressed.

However, unlike the effects of cortisone on the ex

pression of the DH response, mice treated with cortisone, sensitized
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with oxazolone four or six days later, and skin tested after an
additional seven days, respond with increased DH reactivity compared
to untreated control animals.

As mentioned previously, this pxx>-

longed state of depression may be attributed to the "depot" effect.
It is of interest to observe that in the tests performed to determine
the influence of cortisone upon either the afferent or efferent
arm of the DH reaction to oxazolone, the animals recover their
ability to respond normally about ten days after receiving cortisone.
Taken at face value this observation indicates that T cells recover
their ability to become sensitized and to produce lymphokines at the
same time.

There must, however, be a fundamental difference in the

recovery of competent and committed T cells since it requires a
period of about four days before competent cells are sufficiently
activated to produce a state of delayed hypersensitivity (2).
Induction of Humoral Immunity
The effect of hydrocortisone acetate on the afferent arm of
the humoral immune response indicates that T and B cells are dif
ferentially depressed by the drug.

Although the antibody response

of mice to rabbit red blood cells (a T-cell-dependent antigen) is
depressed during the entire interval of study, the response to IÆS
(a T-cell-independent antigen) is depressed only on the first or
second day following administration of cortisone.

During these

two days the spleen size is markedly reduced, and in most animals,
lympAiocytes can not be obtained even from pooled spleen samples.
On the following days, however, the spleens begin to "regenerate",
and B cells, assayed by immunofluorescence, are detected in sus-
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pensions of spleen cells.

The depression of the antibody response

to LPS is undoubtedly due to temporary functional absence of
spleen lymphocytes and circulating B cells.

B cells may be

driven into another body compartment, such as the bone marrow (35)»
but obviously are not present in the spleen.

On the other hand,

B cells are available even though nonfunctional since it is observed
that drug-treated mice are as susceptible to infection with FDV as
are untreated controls.

However, the T lym^^iocytes appear to be

affected in a different manner.

Depression of the antibody

response to red blood cells suggests that T cells may be sequestered
elsewhere in the body and are not available for contact with antigen
or that cortisone alters antigen-recognition thus preventing
stimulation of B cells for antibody production.
The mechanism of action of azathioprine and methotrexate
differs from that of cortisone and from each other.

The antibody

response to rabbit red blood cells is depressed following treatment
with either drug.

However, azathioprine depresses the antibody

response only tdien the drug is administered on the same day or one
or two days prior to injection of antigen, Wiereas methotrexate
depresses the humoral response throughout the entire period of
study.

On the other hand, susceptibility to infection with FDV

decreases during the first two days following administration of
either drug but is more persistent with methotrexate.

These results

indicate that B lymphocytes are either unable to respond to antigen
or are unavailable for contact with antigen.

The similarity in

response of mice given azathioprine and methotrexate to infection
with FDV and the difference in humoral antibody suppression in-
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dlcates that azathioprine is catabolized more rapidly.

The B cells

are susceptible to FDV by eighteen days following drug treatment
but respond to antigenic stimulation four days after azathioprine
treatment and some time past ten days following methotrexate.
Niridazole, however, apparently acts by an entirely different
mechanism than that of the other drugs since no depression of
antibody response or FDV susceptibility is observed.
Since macrophage function was not investigated in this study,
further experiments might indicate whether the depression of DH
and humoral immunity could also be attributed to the inability of
macrophages to process antigen or respond to MIP,
Cortisone
The function of immunosuppressive drugs upon the two types of
lymphocytes is variable, and the temporal effects on either B cells,
T cells, or both will be reflected in the immunological response
of the host.

As shown by other investigators (23» 26 , 40), the

action of glucocorticosteroids on the cellular and humoral immune
responses is dependent upon the effect on the two populations of
lymphoid cells.

Corticosteroids are also used to suppress non

specific inflammatory reactions, and are of value in controlling
allograft rejection.

The DH response is a combination of afferent

and efferent processes.
stimulate T lymphocytes.

Macrophages process antigen and, in turn,
These sensitized lymphocytes subsequently

release chemotactic factors that, in addition to other functions,
inhibit macrophage migration.
Corticosteroids suppress DH although the mechanism of action
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is unclear.

According to Claman (23) and de Sousa and Fkchet (29)

lymphocytes in the cortex of the thymus are steroid-sensitive.
However, these cells become resistant during migration through the
thymus medulla and maintain this resistance during uncommitted and
committed stages of differentiation.

In the mouse system a h i ^

incidence of lysis of the thymus cortical lymphocytes is observed
as early as four hours following cortisone acetate administration
(l4, 29).

By 24 hours cytolysis is complete and all nuclear debris

is removed from the cortex.

In contrast, human and guinea pig

thymus cells are relatively resistant to ^

vitro lysis by

hydrocortisone (24), indicating the species variability to drug
suppression.

Of interest is the observation that the cells subject

to lymphocytolysis eure not immunocompetent since thymus cells from
cortisone treated mice are more active in initiating GVH reactions
than azre thymus cells from untreated animals (25)*
Using BHA-induced lymphocyte transformation as a measure of
cell-mediated immunity, Webel et al (103) report maximal suppression
of blastogenesis of peripheral lymphocytes within four hours
following a single dose of methylprednisolone to human volunteers.
Gradual return to normal lymphocyte transformation is apparent by
72 hours.

On the other hand, pokeweed mitogen stimulation of

lymphocytes from steroid-treated subjects is not significantly
impaired, suggesting a differential suppression of T and B cells.
As shown by Casey and McCall (20) using the macrophage
migration test, the afferent arm of the DH response is inhibited when
rabbits are treated with steroid at the time of sensitization with
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BCG.

If steroid treatment is delayed until BCG sensitization has

developed, inhibition of macroiAiage migration occurs.

Furthermore,

when BCG-sensitized lymphocytes are added to cultures of cells ob
tained from steroid-treated rabbits the inhibition of macrophage
migration is reestablished.

Other researchers (?, 104) conclude

that steroids do not block antigen processing by macrophages or
synthesis of MIP by sensitized lymphocytes.

Balow and Rosenthal (?)

suggest that corticoids interfere with the macrophage response to
MIF, perhaps via some alteration of the macrophage itself.

Such

an alteration m i ^ t be stabilization of the macrophage cell
membrane which could prevent secretion of the macrophage lysosomal
enzymes (82)•
Further data (73, 95) also indicates that macrophage-monocyte
defects may contribute to the steroid-mediated suppression of
cellular immunity which is apparent in patients receiving cor
ticosteroids and manifested as increased susceptibility to
infectious agents.

Monocytes are those circulating cells which re

spond to chemotactic stimuli, such as lymphokines or products of
infectious agents, and mature into macrophages at sites of infection
or inflammation.

Corticosteroids may in fact interfere with inter

action of monocytes and chemotactic stimuli thus inhibiting some
trigger of crucial metabolic events.
In a recent series of papers (91, 92, 93) Stevenson refers to
a polymorph migration stimulator factor (PMS) which is released
from steroid-treated macrophages.

Apparently monocytes interact

with steroid jjj vivo and liberate PMS in vitro resulting in
polymorph migration.

The migration is dependent upon the presence
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of monocytes but not lymphocytes in the test chamber.

Serum from

steroid-treated patients does not stimulate polymorph migration
until the euglobulin fraction is removed. A release of polymorphs
from the bone marrow may be induced by PMS resulting in the increase
of these cells in the circulation following corticosteroid treat
ment.

Since steroids prevent aggregation of polymorphs at in

flammatory lesions (29), Stevenson suggests that PMS may induce
functional changes in polymorphs which prevent their response to
lymphokines or chemotaxins.

In addition, he also indicates that

PMS may not serve a functional role in preventing migration of
polymorphs but that another mechanism might be responsable for
preventing the response of these cells to the soluble mediators
of inflammation.
Parrott et al (65) stress the importance of T cells in in
duction and expression of contact sensitivity in mice.

According to

de Sousa and Fachet (29), cortisone administered prior to a sen
sitizing dose of oxazolone to the ear skin does not eliminate T
cells in the draining lymph node but does prohibit transformation
of these lymphocytes.

When cortisone is administered after

sensitization, transformation of T cells occurs normally, and the
large pyroninophilic blast cells are not affected.

Therefore, these

investigators suggest that the value of cortisone as an immuno
suppressive agent of contact sensitivity depends upon time and the
dose of drug that will impair T cell transformation in the draining
lymph node.

They concede, however, that the impairment may be due

to inhibition of polymorph and macrophage infiltration at the site
of oxazolone application.

Cortisone may also prevent antigen release
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from epidermal cells or antigen transport to the -draining lymph node.
Less work has been done on the effects of steroids on humoral
immunity.

In general, antibody production is inhibited if cortisone

is administered prior to antigenic stimulation.

For example;

Claman (23) proposes that B lymphocytes are steroid-sensitive prior
to contact with antigen but become steroid-resistant following
differentiation into committed B cells.

Elliott and Sinclair (32)

show that both 198 and 78 antibody are maximally suppressed when
cortisone is given three to four days prior to sheep red blood cells.
However, only 78 antibody is suppressed when cortisone is given after
the antigen.

A striking decrease in the peripheral lymphocyte pool

also occurs during suppression of the antibody response.

Although

the necessity of circulating lymphocytes for expression of humoral
immunity is well established (44), defects of antigen trapping and
processing by macrophages, and antigen retention in lymphoid organs
should not be overlooked as possible causes of decreased antibody
levels.

As shown by Petranyi et al (69) induction of memory and

synthesis of ?S antibody appears more susceptible to a single large
dose of cortisone.

However, when cortisone is given from five days

prior to antigen to the day of antigen, enhanced 198 antibody is
apparent during 78 suppression.

As a possible explanation they

suggest that cortisone acts preferentially on the antigen-sensitive
precursor cells.

Since there aæe I5 times less ^

precursor cells

than 19s cells in the bone marrow, this may explain the pronounced
78 antibody suppression.

Also 78 feedback-inhibition of 198

antibody production may allow for the enhanced IgH production.
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According to Cohen and Claman (2?)§ the B cell precursors
are more susceptible to suppression than are the helper T cells.
Spleens of hydrocortisone-treated mice are deficient in antibodyforming cells, and immunocompetence may be restored by repopu
lating the circulatory system of these mice with bone marrow but
not with thymus cells.

These researchers suggest that antibody-

forming precursor cells in the bone marrow and the committed B
cells are corticosteroid-resistant, while immunosuppression of
the humoral response occurs at the level of the antigen-reactive
B cell.
In contrast to other data, Butler (l?) reports a steroidinduced decrease in ongoing IgG synthesis in humans.

He hypothe

sizes that the drug inhibits the committed plasma cell and does
not affect induction of primary or secondary antibody responses.
Another possible explanation of corticoid immunosuppression
involves redistribution of circulating lymphocytes into other body
compartments or arrest of lymphocyte recirculation rather than
corticoid-induced lymphocyte alteration.

Fauci (35) demon

strates the accumulation in the bone marrow of functionally mature
lymphocytes bearing T and B cell markers following steroid treat
ment in guinea pigs.

A similar effect is seen by Cohen (26)

using mice and by Yu et al (108) using human volunteers.
Azathionrine
Azathioprine is used extensively in the treatment of patients
undergoing o r ^ n transplantation or having autoimmune disease.

This

drug is an imidazole derivative of 6-MP and is not immunosuppressive
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until it undergoes cleavage by sulfhydral compounds to release
6-MP.

Depletion of sulfhydral or amine groups during the formation

of 6-MP may contribute to the immunosuppressive effects of azathio
prine.

The drug is broken down to its active form by eirythrocytes

and white blood cells and has a serum half-life of about four hours (31),
Immunosuppressive effects of azathioprine on the cellular
immune responses vary considerably with species, antigen and dosage
although cellular immunity is not generally depressed.

For example,

human volunteers receiving low doses of azathioprine elicit normal
induction and expression of DK to simple chemicals such as poison
ivy allergen, dinitrochlorobenzene (DNCB) (52), and keyhole limpet
hemocyanin (9^).

The Ki response to DNCB in drug-treated guinea

pigs is not suppressed (53)•

On the other hand, the DH response

to tuberculin, diphtheria toxoid and serum albumin is reduced or
delayed in a variety of animals treated with this agent (77).
Multiple dose azathioprine therapy prolongs allogeneic skin graft
survival in rats (79), suggesting suppression of the cellular
immune response.

In general^suppression of the graft rejection

mechanism is more effective when the drug is administered following
antigenic stimulation.

From all of these data it appears that DH

to simple chemicals is more difficult to suppress.
Poulter et al (70) report reduction in thymic weight and in
numbers of lymphoid cells bearing theta antigen in mice treated
with azathioprine.

The population of theta-positive cells is depleted

for three to six days following drug treatment.

As in the studies

using cortisone, T lymphocytes in the thymus cortex are azathioprine-
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sensitive while the T cells of the thymus medulla are resistant.
These authors suggest that azathioprine either deplete

certain

populations of lymphocytes or alters the antigenicity of the
antigen—reactive T cells.

Bach and Dardenne (5) note a selective

suppression by azathioprine of the thymus-derived rosette forming
cells.

The ability of lymphocytes to form rosettes Is an iri vitro

assay for detection of cells bearing theta antigen (6).

The

Incorporation of trltlated thymidine Into mixed lymphocyte cultures
Is decreased when the drug Is Introduced Into the cultures during
the first 24 hours (4), Indicating that this agent may alter
antigen recognition during the early phase of Immune Induction.
Using labeled lymphocytes to observe lymphoid cell migration In
mice, other Investigators find no evidence of cytolytic activity
by azathioprine (38).

Although the drug Is most effective against

cells actively synthesizing DNA (103), Fournier et al (38) show that
cell proliferation Is not suppressed, since lymphocyte migration
does not Involve proliferation.

Suppression of migration of lymphoid

cells to the lymph nodes suggests that azathioprine selectively affects
the short-lived recirculating T lymphocytes (58).

The Inductive

phase of the Immune response Is apparently more susceptible to sup
pression since drug-treated mice acquire resistance to Listeria
monocytogenes following the passive transfer of Immune lymphoid
cells (97).

Although the mechanism of azathioprine-Induced Immuno

suppression Is still unclear, a membrane change Involving the anti
gen receptors probably offers the most reasonable explanation.
In contrast, other Investigators (48) Indicate no reduction
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of rosette forming T cells, casting some doubt on the assumption
of azathloprlne-lnduced alteration of lymphocyte antigenicity.
Azathioprine may also suppress the primary antibody response.
By using a multiple dose regimen, Santos and Owens (78) report a
depression of the antibody response to sheep red blood cells when
drug treatment Is begun one, two, or three days prior to antigen
administration or four days following the antigen.

However,

maximum suppression occurs idien therapy starts on the second day
prior to an Injection of sheep red blood cells.

In addition, the

suppression Is specific since restlmulatlon with the same antigen
elicits no antibody response,but a primary response to a different
antigen Is mounted.

This may Indicate an Inability of committed

T cells to function as helper cells In antibody production.
Selective suppression of 7S antibody occurs with prolonged or
enhanced synthesis of 19S antibody, suggesting that azathioprine
may function at the level of the mechanism resulting In the switch
from an IgM to an IgG-produclng B cell (52, 9^).

Occasionally

enhanced antibody production Is noted In azathioprine-treated
subjects (22, 9^).

If azathioprine Is cytotoxic to lymjdiold cells,

nucleic acid may be released when the cells lyse.

Nucleic acids

are absorbed by living cells and stimulate cell division and protein
synthesis (8).

Therefore, Immature lymphocytes may Incorporate

the nucleic acid and be transformed Into antigen-reactive cells.
Azathioprine has little effect on the secondary antibody
response Indicating that memory cells are resistant to suppression
by this drug (106).
Several workers also suggest that azathioprine may exert

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

72
an anti-inflammatory action.

Borel and Schwartz (15) note

suppression of the passive Arthus reaction, and Page and Condie (64)
indicate that neutrophils appears at the inflammatory site but normal
migration of lymphocytes does not follow.

Perhaps chemotactic

substances are not produced by the neutrophils, or mononuclear
cells may be either destroyed or unresponsive.
Niridazole
Niridazole is a drug used in the treatment of helminthic in
fections such as schistosomiasis.

Mahmoud et al (35) report that

a s i n ^ e low dose of niridazole suppresses granuloma formation
around Schistosoma mansoni eggs in infected mice.

Repeated daily

doses prolong allograft survival in mice when drug treatment is
begun either before or after grafting.

Interpretation of these

results suggests that niridazole therapy produces prolonged sup
pression of cellular immunity.

Consequently, when the granulo

matous response is decreased, eggs mature and hatch, thus facili
tating the extraction of adult worms.

Niridazole is converted

in vitro to water soluble metabolites which bind to serum proteins,
and this conversion may account for the extended suppression (33).
More recently, Daniels et al (28) report that a niridazole meta
bolite found in serum suppresses the DH response of guinea pigs
sensitized with o-chlorebenzoyl-bovine gamma ^obulin.

This

metabolite prevents MIF production by lymphocytes but does not
affect the response of macrophages to preformed MIF,

lymphocyte

incorporation of tritiated thymidine is unaffected in niridazoletreated guinea pigs.

An earlier study by Mousa et al (62) is

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

73
contzadlctive« In that they find repeated injections of a h i ^ dose
of niridazole do not alter established schistosome Infections.

However,

the therapeutic value of niridazole is increased when the drug Is
given pirior to infection.
Decreased bone marrow and white blood cell counts and increased
susceptibility to infection axe not noted following treatment with
niridazole (41, 86),
The influence of this drug on humoral immunity has not been
extensively studied, but Pelley et al (6?) indicate that repeated
doses of niridazole suppress antibody production for a short
duration.

Although the mechanism of action of niridazole is not

understood, several investigators (72) suggest that suppression of
nonspecific inflammatory reactions is involved.
Methotrexate
Methotrexate (amethopterin) is an antimetabolite ihich functions
by competing with folic acid for the enzyme dihydrofolate reductase.
Thus, DNA synthesis is impaired by blocking the major pathway
leading to thymidine formation (66).

The drug is excreted or

metabolized within four hours after administration, but a threshold
amount of the metabolites may persist for up to three weeks in tissues
containing hi^i concentrations of folic acid (37).
In some cases methotrexate prevents development of DH.

For

example, contact sensitivity to DNCB in man (59) and to PPD in
guinea pigs (107) are suppressed.

However, this drug apparently

does not reverse positive skin tests for established DH (47).
Methotrexate does not prevent the development of iramunoblasts in
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lymph nodes following exposure to contact sensitivity agents as
incorporation of tritiated thymidine occurs normally (30).
Inhibition of induction of Mi seems to occur at the level of the
small lymphocytes which develop from immunoblasts.

However, Kessel

et al (50) report that normal and leukemic small lymphocytes are
methotrexate-resistant, but granulocytes take up the drug.

Further

more, a single dose of the agent has no effect on skin graft survival
in rats, but multiple doses suppress graft rejection *Aien drug therapy
is initiated five to seven days after grafting (79).

Methotrexate

has no effect on the established resistance to the intracellular
parasite Listeria monocytogenes. indicating that the suppression is
not directed at macrophages (98).
Methotrexate is more effective in suppressing humoral than
cellular immunity.

Administration of multiple doses of the drug

starting one or two days prior to injection with sheep red blood
cells significantly prolongs primary antibody induction and sup
presses the peak titer (78).

The 7S antibody response is selectively

suppressed when methotrexate is given from two days before to two
days after the antigen (80),

With peripheral blood mixed lymphocyte

cultures, tritiated thymidine incorporation is inhibited up to four
days after beginning the culture (4), suggesting a possible effect
on proliferation of both T and B cells.

When the drug is given four

to seven days prior to injection of the antigen, immunity is actually
enhanced as noted by marked lymphoid hyperplasia (98).

Althou^

the mechanism of enhancement is unclear, this phenomenon implies
that inadequate immunosuppressive therapy may in fact enhance immune
responses,

Maley and Maley (57) suggest that following methotrexate
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treatment, an increase in thymidylate synthetase, an enzyme necessary
for the conversion of deoxyuridylate to deoxythymidylate, may
account for the enhanced immunity by actually stimulating cell
proliferation.
Overview on the Effects by these Four Agents
Data obtained from the cortisone
gation are in agreement with previous

studiesin this investi
resultsindicating that both

cellular and humoral immunity are suppressed.

According to de Sousa

and Fachet (29), transformation of committed T cells is prevented
when cortisone is given prior to a sensitizing dose of oxazolone,
but DH develops normally when cortisone is given after T cell
transformation is initiated.

In this study transformation of

committed T cells is inhibited when cortisone is administered from
zero to four days prior to oxazolone sensitization.

Drug treatment

at earlier times allows development of the DH response in four days
as expected (24).

However, as evidenced by the experiment con

cerning the effect of cortisone on the afferent arm of the DH re
sponse, uncommitted T cells are not affected by cortisone and
undergo normal transformation after a sensitizing dose of oxazolone
to give maximum expression of DH in four days.

Therefore, this

study suggests that cortisone exerts differential suppression on the
population of committed T cells.

With this in mind, cortisone

suppression of macrophage function seems doubtful since macrophages
are involved in both induction and expression of DH,

Cortisone-

induced alteration of antigen recognition offers the most probable
explanation of the mechanism of action of this drug.

Studies
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using passive transfer of sensitized cells would aid in understanding
the mechanism.
The effects of cortisone on humoral immunity are in partial
agreement with this speculation.

Previous investi^tors note that

cortisone suppresses blastogenesis to the T-cell mitogen PHA but
not to the B-cell mitogen pokeweed (103).

Similarly, suppression

of the antibody response to the T-cell-dependent red blood cell
antigen is more pronounced than suppression of the response to the
T-cell-independent LPS antigen.

Again, an alteration in antigen

recognition by T cells is suggested, but in this case, the
uncommitted T cells are involved.
According to the literature, azathioprine and niridazole also
suppzress cellular immunity.

Suppression of the established DH response

by azathioprine from two to six days following the drug administration
corresponds with the absence of theta-bearing T cells noted by
Poulter et al (?0) during this time.
and excreted rapidly.

Azathioprine is metabolized

Thus, the action of this drug on only a

small percentage of -Uie

committed T cells may explain the nominal

suppression and rapid recovery of the DH response observed in this
study.

A single dose of niridazole also causes short-term suppression

of the efferent arm of the DH response which is similar to the
suppression noted with azathioprine.

In both instances alteration

of antigen recognition or cytolysis of committed T cells is imlioated.

The uncommitted T lymphocytes are apparently unaffected

and may respond to antigenic stimulation following elimination of
the drug.
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The B cell function during development of humoral immunity
seems to be resistant to suppression by these two drugs.

In fact,

the antibody response may even be enhanced by azathioprine,

A

cytotoxic effect on lymphocytes could account for this enhancement
by releasing free nucleic acid as described earlier (8),

The

actual mechanism of suppression by these drugs is difficult to
assess with this study because committed T cells are examined in
the expression of DH and uncommitted T cells are examined in the
induction of humoral immunity,
Me-Uiotrexate apparently exerts an entirely different mechanism
of action than the other three drugs and suppresses the B cell
compartment of the immune response.

On the basis of humoral

immunity alone, antibody production and actual numbers of B cells
are reduced, suggesting suppression of lymj^ocyte proliferation.
Immunosuppressive agents may act cooperatively or antago
nistically with immunological defenses, and evidence has accumulated
that interference with the cell-mediated or humoral immune systems
may augment one component while depressing the other.

Cyclo

phosphamide therapy results in depression of the entire immune
response initially but continued depression of humoral immunity
is accompanied by potentiation of cell-mediated immunity (49).
Conversely, sheep red blood cells and LPS antibody responses in
Pseudomonas aeruginosa infected mice are enhanced during depression
of contact sensitivity of oxazolone (l8),

Petranyi et al (69) find

that variations in dose and time of drug administration alter the
antibody response and induce selective enhancement of 19S antibody.
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The T and B cells exert feedback inhibition, and circulating
antibodies may Inhibit development of cell-mediated Immune responses
by activating suppressor T cells (42).
proliferation ensues.

As a result, active T cell

Immunosuppressive drugs may eliminate feed

back Inhibition and suppressor cell populations, resulting in
enhancement rather than suppression of immune responses.
Expanded knowledge of temporal effects of immunosuppressive
drugs has important practical applications in determining drug
regimens in transplant cases and tumor therapy.

Differential

suppression by drugs might modulate the balance between cellular
rejection mechanisms and humoral antibody enhancement.

Although

it is difficult to make generalizations about drug treatment
since dose, schedule, route of administration, individual

variability,

and specificity of lymphoid cell populations introduce considerable
variation, it is reasonable to expect that rational drug management
may modulate the immune response in a practical fashion for human
disease treatment.
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Chapter 5
SUMMARY
Ihe ultimate role of Immunosuppression has been to control
undesirable immune responses without altering the essential immune
mechanism.

However, to initiate reasonable therapeutic regimens,

the effects of Immunosuppressive drugs on the normal immune responses
should first be determined.

In this study the temporal effects of

four drugs on primary antibody production and/or delayed hyper
sensitivity (DH) were examined.

With respect to the time of drug

administration, results indicated that lymphoid cell differentiation
was accompanied by changes in susceptibility to various chemical
agents.
Hydrocortisone acetate, a corticosteroid with anti-inflam
matory properties, suppressed both cellular and humoral immunity.
The effect of hydrocortisone on the established DH response to
oxazolone was more prolonged and severe in comparison with the
drug's effect on induction of the DH response, but this may be
explained on the basis of time involved for drug catabolism.
Induction of antibody production in treated animals indicated that
T lymphocytes were more susceptible than B lymphocytes.

Since

unsensitized T cells, memory T cells, and B cells appeared to be
affected by hydrocortisone, either inability of lymphocytes to
respond to antigen or sequestration of antigen-reactive lymphocytes
in some other body compartment was suggested.
79
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Azathioprine and niridazole suppressed the established DH response,
but the effect did not occur immediately as with cortisone.

Ibis

suggested that an interval of drug modification was required to
render the drugs "active”.

In addition, azathioprine also caused a

brief suppression of antibody production.

Apparently drug modification

required four days, since suppression of DH and humoral immunity
occurred four days following drug treatment.

During this interval

antigen-sensitive lymjrfiocytes were able to differentiate and pro
liferate.

Therefore, because recovery of immune responses occurred

promptly following elimination of drug from the system, azathioprine
and niridazole were probably cytotoxic to the sensitized lymphocytes
and did not inhibit cell proliferation.
Methotrexate, on the other hand, suppressed the B-cell com
partment of the immune response.

Although depression of antibody

production was prolonged in methotrexate treated animals, suscep
tibility to PDV infection gradually returned after catabolism of
the drug.

This suggested that methotrexate suppressed lym^^ocyte

proliferation.
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